Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $150,920 - $180,699
-440 Reduced 27.92%
1,136 $462,000
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $24,348 - $26,097
-72 Reduced 4.37%
1,576 $548,000
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $27,668 - $30,968
88 Added 5.64%
1,648 $579,000
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $12,462 - $14,216
-44 Reduced 2.74%
1,560 $491,000
Q4 2022

Feb 15, 2023

SELL
$285.76 - $321.48 $5,715 - $6,429
-20 Reduced 1.23%
1,604 $463,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $444,699 - $496,180
1,624 New
1,624 $470,000
Q1 2022

May 12, 2022

SELL
$221.42 - $260.97 $550,671 - $649,032
-2,487 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $440,223 - $555,720
2,487 New
2,487 $546,000
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $428,261 - $479,259
-2,361 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$187.49 - $221.1 $17,624 - $20,783
94 Added 4.15%
2,361 $477,000
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $70,386 - $82,045
340 Added 17.64%
2,267 $488,000
Q4 2020

Feb 04, 2021

BUY
$207.01 - $276.09 $389,799 - $519,877
1,883 Added 4279.55%
1,927 $456,000
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $11,248 - $13,336
44 New
44 $12,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Founders Financial Alliance, LLC Portfolio

Follow Founders Financial Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Alliance, LLC with notifications on news.